T h e physiological release of neutrotransmitters and peptide hormones from neural and endocrine cells is regulated by a calcium-dependent membrane fusion apparatus that controls the exocytotic fusion of secretory vesicles with the plasma membrane. Many of the gene products that are required for regulated exocytosis have been identified, and some of the mechanisms responsible for membrane fusion have been characterized to a limited extent [ 1-41. Several years ago an unanticipated role for phosphoinositides in this process was discovered [S-71. T h e evidence that inositide phosphorylation is required for membrane fusion, and efforts to elucidate the role of PtdIns(4,5)P2 in regulated exocytosis will be discussed.
Background
A number of studies of regulated fusion have used permeable secretory cells to provide access to the exocytotic apparatus. Adrenal chromaffin 'To whom correspondence should be addressed. cells and immortalized PC 12 cells have advantages for these studies, which include the extensive background of biochemical studies of the catecholamine-storing chromaffin granule. Early studies discovered a resident PtdIns 4-kinase activity on chromaffin granules [8-lo] , a finding that has been generalized to many other secretory vesicles. In prescient studies, Holz and co-workers
[S] discovered that calciumdependent noradrenaline secretion in digitoninpermeabilized chromaffin cells was inhibited by treatment with a PtdIns-specific phospholipase C. Additional studies suggested to the authors that the ATP dependence of calcium-activated noradrenaline secretion might reside with the process of lipid phosphorylation and synthesis of PtdIns ( 4,5)P2.
With extensively permeabilized PC12 cells, we sought to determine the mechanisms underlying the ATP-dependence of regulated secretion. An ATP-dependent priming step was found to precede and to be required for the subsequent calcium-activated membrane fusion step [ 111.
ATP-dependent priming exhibited a requirement
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for three cytosolic factors that were resolved by gel-filtration chromatography. These were termed PEP1, -2 and -3 (in order of elution) for 'priming in exocytosis proteins'. Following purification and sequencing, the smallest of these (PEP3) was revealed to be the a isoform of PtdIns transfer protein [6] . Since this protein does not require ATP for in vitro phospholipid transfer, it seemed likely that its function in regulated secretion was coupled to an ATPdependent process. This was confirmed to be the case upon characterization of PEPl as consisting, at least in part, of the brain ty-pe I isoform of PtdIns4P 5-kinase [7] .
The identification of two of the PEP proteins as constituents in a pathway for PtdIns(4,5)Pz biosynthesis provided direct evidence for the suggestion of Eberhard et al. [5] that inositide phosphorylation played a role in the ATP-dependent priming of regulated exocytosis. Synergy between PEPl and PEP3 further indicated their participation in a common pathway [7] . Recently, Wiedemann et al. [12] provided evidence that the chromaffin granule PtdIns 4-kinase is also essential for calcium-activated exocytosis. A number of studies indicate PtdIns(4,5)Pz is required for membrane fusion. Either hydrolysing the lipid with phospholipase C or binding it with specific monoclonal antibodies resulted in a very strong inhibition of calcium-activated membrane fusion in ATP-primed permeable PC12 cells [7] . The fact that Ca2+-activated secretion is highly sensitive to neomycin or many other basic substances (e.g. Lys-rich peptides) may also be related to this requirement. Recently, genetic evidence that PtdIns transfer protein and PtdIns4P 5-kinase are essential for nervous system function was reported [ 13,141. Membrane trafficking defects in yeasts harbouring PtdIns transfer protein (SEC14) or 5-kinase (FAB1) mutations have also been described [ 15,161. Unlike the role of PtdIns(4,5)P2 in signal transduction, where it serves as a precursor for hydrolysis to lipid-derived metabolites, it is likely that the intact phosphoinositide is required for membrane fusion. PtdIns-specific phospholipase C [5] and a recombinant mammalian phospholipase C [7] inhibit rather than stimulate secretion, indicating that a metabolite derived from phospholipase C hydrolysis is not involved. A number of metabolites and related compounds have been tested in permeable cells for effects on secretion. At concentrations up to 100 pM, inosito1 polyphosphates, PtdIns, PtdIns4P, glycerolphosphorylinositol bisphosphate, arachidonic acid and phosphatidic acid have minimal effects on secretion. The effects of diacylglycerol could not be interpreted since it caused granule lysis but not fusion. Interestingly, PtdIns(4,5)Pz is strongly inhibitory at low concentrations (Figure l) , whereas equal concentrations of PtdIns(3,4,5)P3 fail to inhibit (and may slightly stimulate) calcium-activated secretion. Presumably the inhibitory effects of PtdIns(4,5)Pz result from competition with endogenous phosphoinositide-binding proteins. Overall, the results indicate that the PtdIns(4,5)P2 synthesized during ATP-dependent priming is not employed as a precursor for the generation of lipid-derived metabolites that function in fusion.
Like the process of inositide phosphorylation, priming of exocytosis had been found to be fully reversible [ 111. While the ATP-dependent priming process was dependent upon a PtdIns4P 5-kinase, the reversal of priming appears to involve a 5-phosphatase (Figure 2 ). This was suggested by the accelerated reversal of priming by cytosol and Mgz+. Although the cytosolic factor remains to be characterized, the provision of a recombinant type I1 inositol phosphate 5-phosphatase [17] was found to accelerate the reversal of priming in a manner similar to cyto- sol. These preliminary studies were consistent with a cycle involving 5-kinase and 5-phosphatase as the basis for priming and its reversal. The recent characterization of a synaptic type I1 5-phosphatase [18] , suggested to play a role in synaptic vesicle endocytic retrieval, raises the possibility that regulation of phosphoinositide phosphorylation may control the fate of vesicle membrane toward exocytic or endocytic destinations. Whereas the preceding evidence indicates a role for PtdIns(4,5)Pz in regulated exocytosis, it was possible that this role was to serve as a precursor for formation of a 3-phosphorylated inositide. PtdIns or PtdIns(4,5)Pz 3-kinases have been shown to play a role in the sorting of proteins to the vacuole in yeast [19] , and in endosomal and lysosomal protein sorting in mammalian cells [ZO-221. Much of the work in mammalian cells has employed PtdIns 3-kinase inhibitors such as wortmannin or LY294002. As shown in Figure 3 , the ATP-dependent priming of calcium-activated exocytosis in permeable PC12 cells was largely insensitive to either wortmannin or LY294002. On this basis, it can be concluded that an inhibitor-sensitive lipid kinase is not required for priming the exocytotic apparatus.
Ptdlns(4,5)P2 synthesis on docked granules
An important step toward elucidating the mechanism for PtdIns(4,5)Pz involvement in membrane fusion is to determine in which membrane (s) lipid phosphorylation occurs during ATP-dependent priming. This was recently accomplished in immunocytochemical studies with a PtdIns(4,5)PZ-specific monoclonal antibody (K. M. Loyet, F. Fukami, T. Takenarva and T. F. J. Martin, unpublished work). PC12 cells were mechanically permeabilized, incubated under conditions that prime or reverse priming, and tethered on to glass coverslips. Without fixation, the permeable cells were incubated with anti-PtdIns(4,5)PZ antibodies and fluorescent secondary antibodies. At high dilutions of the primary antibody, fluorescence was restricted to a punctate array close to the plasma membrane. The fluorescence was dependent upon incubation with MgATP, and eliminated by treatment with phospholipase C. The punctate nature of the fluorescence, and its proximity to the plasma membrane, suggested that the PtdIns(4,5)P2 was on secretory granules. This was confirmed by fluorescence co-localization studies with antibodies to chromogranin B, a granule-specific
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constituent, and by immunogold electron microscopy. Calibration of the immunofluorescence with liposomes containing known amounts of PtdIns(4,5)Pz showed that detection required PtdIns(4,5)P2 concentrations in excess of 10 mol%.
Effectors of Ptdlns(4,5)P2 in regulated exocytosis
The high negative charge, strong degree of hydration and the positive curvature of the extremely high concentrations of PtdIns(4,5)Pz formed on the secretory vesicle would probably inhibit membrane fusion based on any of the mechanisms that have been proposed for fusion [23] . Thus it seems likely that the PtdIns(4,5)Pz would need to be sequestered away from active points of fusion, possibly by phosphoinositidebinding proteins. PtdIns(4,5)Pz-binding proteins have the capability of segregating this lipid into domains that contain the lipid and the binding protein and exclude other constituents in the membrane [24] . Recently, a large number of phosphoinositide-binding proteins have been identified in efforts to elucidate the effectors of PtdIns(4,5)Pz, PtdIns(3,4,5)P3, PtdIns(3,4)Pz and PtdIns3P for growth regulation, cytoskeletal rearrangements and membrane trafficking [25, 26] . Several distinct phosphoinositide-binding motifs have been found to mediate phosphoinositide-protein interactions, including PH domains, Lys/Arg-rich regions as well as many others. At the present time, the effectors for PtdIns(4,5)Pz in membrane fusion remain to be identified. Synaptotagmin, a candidate calcium sensor for exocytosis, was reported to engage in calcium-stimulated interactions with PtdIns(4,5)Pz [27] , raising the possibility that this vesicle protein could act to sequester PtdIns(4,5)Pz in preparation for fusion. Consistent with this suggestion, recent studies demonstrated that InsP6, which competitively interferes with synaptotagmin C2B domain interactions with PtdIns(4,5)P2, inhibits neurotransmitter release in a manner reversed by anti-(synaptotagmin CZB) antibodies [27, 28] . Recent studies also document a highly specific interaction of PtdIns(4,5)Pz with CAPS (K. M. Loyet, A.
Chaudhary, G. D. Prestwich and T. F. J. Martin, unpublished work), the vertebrate homologue of Cuenorhubditis eleguns UNC-3 1 protein, which acts at a late post-priming step in regulated exocytosis [29, 30] . Studies are in progress to test the involvement of PtdIns(4,5)P2 binding in the essential role of CAPS for regulated membrane fusion as well as to identify additional potential effectors for PtdIns(4,5)Pz. 
Introduction
The yeast protein Vps34p is a phosphatidylinositol-specific phosphoinositide PtdIns 3-kinase. This is the first identified member of one class of the general family of phosphoinositide 3-kinases termed PI 3-kinases in eukaryotic cells [1, 2] . Multiple classes of PI 3-kinases have been isolated, and classification of these enzymes is made on the basis of their amino acid sequence, Abbreviations used: CPY, carboxypeptidase Y; PI 3-kinase, general phosphoinositide 3-kinase; PtdIns 3-kinase, specific phosphatidylinositol 3-kinase. 'To whom correspondence should be addressed. substrate specificity, sensitivity to inhibitory drugs and assignment to a specific signalling pathway. A receptor-tyrosine-kinase-associated form was identified in bovine brain, and is a heterodimeric enzyme composed of a regulatory 85 kDa subunit and a catalytic 110 kDa subunit [3] . A G-protein-activated form was cloned from a human U937 leukaemic cell line cDNA library, and consists of a pllOy enzyme that does not associate with a p85 regulatory subunit [4, 5] . Both of the receptor-linked enzymes can utilize PtdIns, PtdIns4P and PtdIns(4,5)Pz as substrates [3, 4] . A third type of PI 3-kinase was originally identified in Drosophila as PI3K-68D and is
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